Close

Seattle Genetics (SGEN), Bristol-Myers Squibb (BMY) to Collaborate on Adcetris and Opdivo

January 12, 2015 8:11 AM EST Send to a Friend
Seattle Genetics, Inc. (Nasdaq: SGEN) and Bristol-Myers Squibb Company (NYSE: BMY) today announced that the companies have entered into a ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login